Year: 2022
Type: erratum
Abstract: This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS.
Source: Life Science Alliance
Institutions: Boston Children's Hospital, Harvard University, Shanghai Jiao Tong University, Shanghai Sixth People's Hospital, Northeastern University, Deakin University, XinHua Hospital, Shanghai Industrial Technology Institute, Shanghai Center For Bioinformation Technology, Brigham and Women's Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,500
OpenAlex ID: W4307495278